Post a Comment Print Share on Facebook
Featured Feijóo Policía Escrivá Japón Irán

RELEASE: ArisGlobal helps Boehringer Ingelheim transform security signal processing

(Information sent by the signatory company).

- 4 reads.

RELEASE: ArisGlobal helps Boehringer Ingelheim transform security signal processing

(Information sent by the signatory company)

- ArisGlobal helps Boehringer Ingelheim transform safety signal processing by leveraging the latest LifeSphere solutions

LifeSphere Clarity drives efficiency and reinvents how Boehringer Ingelheim pharmaceutical operations address safety signals

BOSTON, May 1, 2024/PRNewswire/ -- ArisGlobal, the market leader in Life Sciences technology and creator of LifeSphere®, today announced that research-driven global pharmaceutical company Boehringer Ingelheim is adopting the new transformative functionality of LifeSphere® Clarity™.

LifeSphere Clarity goes where traditional signal detection leaves off, providing access to knowledge graphs, association graphs, medical case clustering, and more advanced features to drive better understanding of the “why” of safety-relevant events and more efficient and standardized risk management for patient safety and pharmacovigilance teams.

Boehringer Ingelheim's own patient safety teams created advanced signal detection technology in situ. ArisGlobal acquired the technology in 2023 and has continued to develop the product, most notably moving the offering to the cloud under the name LifeSphere Clarity. Today, LifeSphere Clarity adds value to the LifeSphere Signal solution

The roadmap for the LifeSphere Signals ecosystem builds on this, including proactive signal detection and leveraging real-world data (RWD), powered by LifeSphere® NavaX™, ArisGlobal's cognitive computing engine, paving the way for path for advanced AI and Generative AI (GenAI) functionality.

Providing a powerful, flexible and highly scalable cloud-based solution that benefits from intelligent automation, LifeSphere Clarity can:

Dr. Robert Buchberger, Senior Vice President, Patient Safety and Pharmacovigilance, Boehringer Ingelheim, said: “We are very proud of the innovation of the original signals, developed in-house at Boehringer Ingelheim. It is gratifying to note that this solution will now benefit the entire industry. “Using advanced technology and its inherent flexibility allows us to stay one step ahead in security data analysis, fulfilling a key part of our mission to transform lives for generations.”

Ann-Marie Orange, Chief Information Officer and Global Head of R&D at ArisGlobal, commented: “A key tenet of our LifeSphere roadmap is to deploy the most advanced and proven technologies for the direct and tangible benefit of our customers and, ultimately, from the patients. Working closely with Boehringer Ingelheim on the conception of Clarity and leveraging the power of knowledge graphs through a streamlined cloud solution within our LifeSphere ecosystem, has allowed us to further meet the evolving needs of bespoke security teams. that pressures on resources continue to intensify. “Clarity, like the broader LifeSphere portfolio, helps biopharmaceutical companies streamline critical R&D processes and deliver more to patients through advanced and efficient risk management.”

About Boehringer IngelheimBoehringer Ingelheim works on revolutionary therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned since, Boehringer Ingelheim takes a long-term sustainable perspective. More than 53,000 employees serve more than 130 markets in the two business units, Human Pharma and Animal Health.

About ArisGlobalArisGlobal is the creator of LifeSphere, a market leader in global patient care technology solutions that is transforming the way today's most successful life sciences companies develop breakthroughs and bring new products to market. More than 500 pharmaceutical and biotech companies around the world (90% of the top 10 pharmaceutical brands) actively use LifeSphere, ArisGlobal's open R&D and compliance platform today. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more information, follow ArisGlobal on LinkedIn or via

Logo -

View original content: